Radiopaque intraluminal stent
The present invention includes a radiopaque stent comprising a cylindrical main body. The tubular main body comprises a cobalt chromium alloy that comprises cobalt, chromium and one or more radiopaque materials.
1. A radiopaque stent, comprising:
a tubular body comprising a cobalt-chromium alloy including cobalt and chromium, the cobalt-chromium alloy including tungsten as a radiopaque element, the radiopaque element being about 30 percent by weight of the cobalt-chromium alloy;
wherein the cobalt-chromium alloy further comprises manganese, the manganese being present in a concentration of up to about 5% by weight, wherein the cobalt-chromium alloy is substantially free of molybdenum, the cobalt-chromium alloy includes one of silicon, phosphorus, carbon, and sulfur being present in a concentration of greater than 0 percent and less than about 1 percent by weight.
2. The radiopaque stent of claim 1 , wherein the cobalt-chromium alloy comprises chromium in an amount from about 10% to about 25% by weight of the cobalt-chromium alloy.
3. The radiopaque stent of claim 1 , wherein the cobalt-chromium alloy comprises no more than 1% molybdenum by weight.
4. The radiopaque stent of claim 1 , wherein the cobalt-chromium alloy is entirely free of molybdenum.
5. The radiopaque stent of claim 1 , wherein the tubular body comprises a single tube.
6. The radiopaque stent of claim 1 , wherein the entirety of the tubular body is fabricated from the cobalt-chromium alloy comprising cobalt, chromium, and the radiopaque element.
7. The radiopaque stent of claim 1 , wherein the tubular body comprises one or more wire elements welded together that are made from the cobalt-chromium alloy.
8. A radiopaque stent, comprising:
a tubular body comprising a cobalt-chromium alloy including cobalt and chromium, the cobalt-chromium alloy including tungsten as a radiopaque element, the radiopaque element being more than 20 percent to about 30 percent by weight of the cobalt-chromium alloy;
wherein the cobalt-chromium alloy further comprises manganese in a concentration of up to about 5% by weight and further includes molybdenum, silicon, phosphorus, carbon, and sulfur, each being present in a concentration of greater than 0and less than about 1% by weight.
9. The radiopaque stent of claim 8 , wherein the cobalt-chromium alloy comprises chromium in an amount from about 10% to about 25% by weight of the cobalt-chromium alloy.
10. The radiopaque stent of claim 8 , wherein the tubular body comprises a single tube.
11. The radiopaque stent of claim 8 , wherein the entirety of the tubular body is fabricated from the cobalt-chromium alloy comprising cobalt, chromium, and the radiopaque element.
12. The radiopaque stent of claim 8 , wherein the tubular body comprises one or more wire elements welded together that are made from the cobalt-chromium alloy.
13. The radiopaque stent of claim 8 , wherein the cobalt-chromium alloy is substantially free of molybdenum.
14. The radiopaque stent of claim 8 , wherein the cobalt-chromium alloy comprises no more than 1% molybdenum by weight.
15. A radiopaque stent, comprising:
an elongate, tubular body comprising a cobalt-chromium alloy including cobalt and chromium, the cobalt-chromium alloy including one or more radiopaque elements comprising tungsten, the tungsten element being about 25 percent by weight of the total cobalt-chromium alloy;
wherein the cobalt-chromium alloy further comprises manganese in a concentration of up to about 5% by weight and further includes molybdenum, silicon, phosphorus, carbon, and sulfur, each being present in a concentration of greater than 0 and less than about 1% by weight.
16. The radiopaque stent of claim 15 , wherein the tungsten comprises about 30 percent by weight of the cobalt-chromium alloy.